About LaCell
LaCell is a Healthcare company based in New Orleans (United States) founded in 2010. Stem Cell Production. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Biorepository. Its competitors include BioLife Solutions, RoosterBio and ArunA Bio; 2 of its 3 listed competitors have raised funding.
Company details
LaCell focuses on the production of stem cells for scientific investigators in the academic and biotechnology research community. The company plans to facilitate to clinical translation and regulatory approval of stem cells as regenerative therapies. Its product portfolio includes human adult stem cell, murine stem cell, and medium saline reagents.
- Headquarters New Orleans, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website lacell-usa.com
- Social LinkedIn
- Latest Funding Round$225K (USD), Grant
Jul 2016
- InvestorsHHS
& 1 more
Funding Insights of LaCell
- Total Rounds 2
- Last Round Grant — $225,000
- First Round $1.41M
(Aug 2012)
- Investors Count 2
All 2 funding rounds of LaCell with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2016 | $225,000 | Grant | – | – | |
| Aug 2012 | $1.41M | Grant | – | – |
2 investors in total: 2 institutional.
Investors in LaCell
LaCell has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for LaCell
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of LaCell
3 dated milestones of LaCell across 6 years, from founding to its latest funding, stage changes and deals.
- Founded LaCell is founded.
- Funding First funding round of $1.4M.
- Funding Latest funding round, Grant, of $225K.
Competitors of LaCell
LaCell has 3 listed competitors in our database, 2 of them funded. They include BioLife Solutions, RoosterBio and ArunA Bio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biolifesolutions.com | 1987 | Bothell, United States | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | ||
| roosterbio.com | 2012 | Frederick, United States | $38.41M | 69 | Developer of human mesenchymal stem cells and extracellular vesicles | |
| arunabio.com | 2017 | Athens, United States | $38.51M | Neural exosome platform is developed for neurodegenerative disease therapeutics. |
Detailed competitors of LaCell
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as LaCell (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about LaCell
LaCell was founded in 2010 and raised its 1st funding round 2 years after it was founded.
LaCell is headquartered in New Orleans, United States. It is registered at New Orleans, Louisiana, United States.
LaCell focuses on the production of stem cells for scientific investigators in the academic and biotechnology research community. The company plans to facilitate to clinical translation and regulatory approval of stem cells as regenerative therapies. Its product portfolio includes human adult stem cell, murine stem cell, and medium saline reagents.
LaCell's top competitors include RoosterBio, BioLife Solutions and ArunA Bio.
LaCell has 2 investors. Key investors include HHS, and National Science Foundation.